407:
38:
230:
223:
216:
134:
55:
448:
477:
366:
441:
351:
467:
434:
383:
130:
316:
371:
340:
159:"Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion"
472:
208:
97:
265:
406:
180:
418:
414:
256:
243:
170:
157:
Bourreli, B.; Pinaud, M.; Passuti, N.; Gunst, J. P.; Drouet, J. C.; Remi, J. P. (1988).
377:
67:
60:
461:
291:
109:
72:
306:
247:
240:
198:
301:
296:
285:
126:
119:
114:
104:
42:
28:
330:
325:
184:
85:
37:
175:
158:
212:
201:. WHO Collaborating Centre for Drug Statistics Methodology.
422:
135:
339:
315:
275:
255:
79:
66:
54:
49:
21:
152:
150:
442:
224:
8:
449:
435:
231:
217:
209:
174:
129:; but they are classified as such in the
146:
18:
7:
403:
401:
421:. You can help Knowledge (XXG) by
125:Chemically, the latter two aren't
14:
405:
199:"ATC/DDD Index 2021: code C02DB"
36:
163:Canadian Journal of Anesthesia
1:
478:Antihypertensive agent stubs
494:
400:
361:
317:Potassium channel openers
131:World Health Organization
84:
35:
26:
341:Calcium channel blockers
259:(arterioles and venules)
468:Antihypertensive agents
417:-related article is a
98:antihypertensive drugs
277:Hydrazinophthalazines
94:Hydrazinophthalazines
22:Hydrazinophthalazine
388:Never to phase III
176:10.1007/BF03010617
430:
429:
398:
397:
244:antihypertensives
239:Nonsympatholytic
91:
90:
50:Class identifiers
485:
451:
444:
437:
415:antihypertensive
409:
402:
257:Nitrovasodilator
233:
226:
219:
210:
203:
202:
195:
189:
188:
178:
154:
40:
19:
493:
492:
488:
487:
486:
484:
483:
482:
458:
457:
456:
455:
399:
394:
393:
378:Clinical trials
357:
335:
311:
271:
251:
237:
207:
206:
197:
196:
192:
156:
155:
148:
143:
96:are a class of
45:
17:
12:
11:
5:
491:
489:
481:
480:
475:
470:
460:
459:
454:
453:
446:
439:
431:
428:
427:
410:
396:
395:
392:
391:
390:
389:
386:
375:
369:
363:
362:
359:
358:
356:
355:
346:
344:
337:
336:
334:
333:
328:
322:
320:
313:
312:
310:
309:
304:
299:
294:
289:
282:
280:
273:
272:
270:
269:
262:
260:
253:
252:
238:
236:
235:
228:
221:
213:
205:
204:
190:
169:(3): 242–248.
145:
144:
142:
139:
123:
122:
117:
112:
107:
89:
88:
82:
81:
77:
76:
70:
68:Mode of action
64:
63:
58:
52:
51:
47:
46:
41:
33:
32:
24:
23:
15:
13:
10:
9:
6:
4:
3:
2:
490:
479:
476:
474:
471:
469:
466:
465:
463:
452:
447:
445:
440:
438:
433:
432:
426:
424:
420:
416:
411:
408:
404:
387:
385:
382:
381:
379:
376:
373:
370:
368:
365:
364:
360:
354:
353:
348:
347:
345:
342:
338:
332:
329:
327:
324:
323:
321:
318:
314:
308:
305:
303:
300:
298:
295:
293:
292:Dihydralazine
290:
287:
284:
283:
281:
278:
274:
267:
266:Nitroprusside
264:
263:
261:
258:
254:
249:
245:
242:
234:
229:
227:
222:
220:
215:
214:
211:
200:
194:
191:
186:
182:
177:
172:
168:
164:
160:
153:
151:
147:
140:
138:
136:
132:
128:
121:
118:
116:
113:
111:
110:Dihydralazine
108:
106:
103:
102:
101:
99:
95:
87:
83:
78:
74:
73:Smooth muscle
71:
69:
65:
62:
59:
57:
53:
48:
44:
39:
34:
31:
30:
25:
20:
473:Phthalazines
423:expanding it
412:
349:
343:(arterioles)
319:(arterioles)
307:Pildralazine
279:(arterioles)
276:
241:vasodilatory
193:
166:
162:
127:phthalazines
124:
93:
92:
80:Legal status
27:
374:from market
302:Cadralazine
297:Endralazine
286:Hydralazine
120:Endralazine
115:Cadralazine
105:Hydralazine
100:including:
86:In Wikidata
43:Hydralazine
462:Categories
141:References
29:Drug class
16:Drug class
384:Phase III
372:Withdrawn
331:Diazoxide
326:Minoxidil
75:relaxant
56:ATC code
185:3383316
367:WHO-EM
183:
413:This
61:C02DB
419:stub
352:list
350:see
181:PMID
248:C02
171:doi
137:.
133:'s
464::
380::
179:.
167:35
165:.
161:.
149:^
450:e
443:t
436:v
425:.
288:#
268:#
250:)
246:(
232:e
225:t
218:v
187:.
173::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
